Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.72
Delayed Data
As of Apr 24
 +0.18 / +11.69%
Today’s Change
0.75
Today|||52-Week Range
1.88
+73.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-20.8M-2.8M18.2M28.8M
 
 
 
 
 
Depreciation5.3M4.3M232.0K0.00
 
 
 
 
Total Other Cash Flow5.1M16.3M-1.2M-61.0K
 
 
 
 
 
Funds From Operations-10.4M17.8M17.2M28.7M
 
 
 
 
 
Funds From/For Other Operating Expenses2.4M9.3M3.2M-3.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-12.7M8.5M14.0M32.3M
 
 
 
 
 
 
InvestingIncrease In Investments-263.1M-208.3M0.000.00
 
 
 
Decrease In Investments104.4M305.8M118.9M0.00
 
 
 
 
Capital Expenditures-630.0K-23.0K0.00--
 
 
 
Fixed Asset Disposal4.0K9.0K2.2M151.0K
 
 
 
 
 
Net Cash Flow Investing-159.2M97.6M121.1M151.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-5.0M-13.9M-115.8M0.00
 
 
 
 
Net Proceeds Stock Sale5.9M130.0K12.0K0.00
 
 
 
 
Common Preferred Redeemed-120.8M-31.7M0.000.00
 
 
 
Common Dividends0.00-87.3M-89.8M-4.4M
 
 
 
 
Cash Dividends Paid - Total0.00-87.3M-89.8M-4.4M
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing1.3M161.0K316.0K30.0K
 
 
 
 
 
Net Cash Flow - Financing-121.2M-133.0M-206.0M-4.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-293.2M-27.0M-70.8M28.0M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account